A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Abemaciclib
Related studies linked through entity extraction aliases.
A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
The Finnish National Study to Facilitate Patient Access to Targeted Anti-cancer Drugs
- Status
- RECRUITING
- Phase
- PHASE2
Description of Treatment Patterns and Description and Comparison of Healthcare Resource Utilization and Costs of Women With Metastatic HR+/HER2- Breast Cancer Treated With CDK4/6 Inhibitors
- Status
- COMPLETED
- Phase
- N/A
A Real-world Analysis of Concomitant Medication Use Among Metastatic Breast Cancer Patients Treated With CDK4/6 Inhibitors
- Status
- COMPLETED
- Phase
- N/A
Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
SARC041: Study of Abemaciclib Versus Placebo in Patients with Advanced Dedifferentiated Liposarcoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Stereotactic Radiation & Abemaciclib in the Management of HR+/HER2- Breast Cancer Brain Metastases
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Abemaciclib Plus Ramucirumab for Esophageal/Gastroesophageal Junction Ca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)
- Status
- RECRUITING
- Phase
- PHASE3
Analysis of Therapy Sequence in Women With HR+, HER2 - mBC in Moscow: A Multicenter Retrospective Observational Study.
- Status
- UNKNOWN
- Phase
- N/A
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Safety and Oversight of the Individually Tailored Treatment Approach: A Novel Pilot Study
- Status
- TERMINATED
- Phase
- NA
Phase Ib/II Trial of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to HR+/Her2- Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2